Imagen Technologies

Imagen Technologies is a healthcare technology company that provides AI-powered diagnostic imaging solutions. It was founded in 2015 and is headquartered in New York, NY. The company focuses on integrating diagnostic imaging into primary care practices to improve accuracy, accessibility, and efficiency.

Imagen’s services include Diagnostics-as-a-Service (DaaS), which enables primary care providers to conduct on-site imaging and receive AI-assisted reports. The company offers FDA-cleared AI software, including OsteoDetect, which identifies distal radius fractures, FractureDetect, which detects musculoskeletal fractures, and ChestCAD, which analyses chest X-rays for abnormalities. These technologies reduce diagnostic errors and improve patient outcomes.

The company provides permanent on-site diagnostic imaging, eliminating the need for external referrals. It also offers a TeleSpecialist Network, which gives virtual access to board-certified specialists in fields such as cardiology and orthopaedics. Imagen’s AI-driven software automatically documents findings, supporting physicians in making accurate diagnoses.

Imagen Technologies is led by Co-Founder and CEO Alex Dresner, along with a leadership team that includes Co-Founder and CTO Rob Lindsey, CMO Scott Howell, and SVP of Engineering Jonathan Lee. The company has received $75 million in Series C funding, with backing from GV (Google Ventures), Casdin Capital, and Threshold.

The company reports significant improvements in diagnostic accuracy, including a 73% reduction in life-threatening clinical misses and a 48% increase in Aortic Atherosclerosis detection for patients aged 65 and above. 96% of patients recommend physicians who use Imagen’s services.

Imagen’s goal is to make high-quality diagnostic imaging more accessible using AI and cloud-based data infrastructure. It aims to enhance early disease detection, patient experience, and practice efficiency. The company continues to expand its solutions, shaping the future of AI-powered diagnostics in healthcare.

Imagen Technologies was founded in 2015 with the goal of integrating advanced technology into diagnostic imaging. The company was established to improve access to medical imaging for primary care practices and enhance diagnostic accuracy using artificial intelligence. 

Its founders, including Alex Dresner, identified gaps in traditional diagnostic methods that often resulted in missed diagnoses and delays in treatment. They sought to create a solution that would allow primary care physicians to provide on-site imaging and receive AI-assisted reports, eliminating the need for external referrals.

In its early years, Imagen focused on developing AI-powered software to assist physicians in detecting medical conditions. The company created several AI-based diagnostic tools, including OsteoDetect, a system designed to identify distal radius fractures, FractureDetect, which helps detect musculoskeletal fractures, and ChestCAD, a tool that analyses chest X-rays for abnormalities. 

These systems were developed to improve diagnostic efficiency and reduce errors in identifying medical conditions. Imagen obtained FDA clearance for its software, allowing its products to be used in clinical settings.

As the company expanded, it introduced the Diagnostics-as-a-Service (DaaS) model, enabling primary care practices to conduct diagnostic imaging on-site with AI-assisted analysis. This model provided physicians with immediate results and reduced the reliance on external imaging facilities. Imagen also launched a TeleSpecialist Network, allowing primary care providers to consult with board-certified specialists remotely. These services improved patient care by ensuring faster diagnoses and treatment plans.

Over the years, Imagen secured funding to support its expansion. In its latest funding round, the company raised $75 million in Series C funding from investors including GV (Google Ventures), Casdin Capital, and Threshold. With this investment, Imagen continued to enhance its technology and expand its reach within the healthcare sector.

Imagen reports significant improvements in diagnostic accuracy and patient outcomes. Studies conducted by the company show a 73% reduction in life-threatening clinical misses and a 48% increase in Aortic Atherosclerosis detection among patients aged 65 and above. Additionally, 96% of patients who received care from physicians using Imagen’s technology reported a positive experience.

Today, Imagen Technologies continues to expand its role in AI-powered diagnostics. It provides primary care practices with permanent on-site imaging capabilities and AI-assisted reporting to improve efficiency and accuracy. The company’s cloud-based infrastructure supports seamless integration into healthcare facilities, and its AI software ensures consistency in diagnostic analysis. Imagen remains committed to improving early disease detection and making high-quality diagnostic imaging accessible in primary care settings.

Imagen Technologies aims to improve diagnostic imaging by making it more accurate, accessible, and efficient for primary care practices. The company provides AI-powered solutions that help physicians detect medical conditions early, reducing errors and improving patient outcomes. By integrating on-site imaging with AI-assisted analysis, Imagen enables healthcare providers to offer immediate diagnostic results, reducing delays in treatment. Its TeleSpecialist Network connects primary care doctors with board-certified specialists, ensuring expert opinions when needed. Imagen’s mission is to use artificial intelligence and cloud-based technology to support primary care physicians in delivering better healthcare while improving efficiency and accessibility in diagnostics.

Imagen Technologies envisions a future where every primary care practice has access to advanced diagnostic imaging without the need for external referrals. The company aims to set a new standard in healthcare by combining artificial intelligence, cloud technology, and expert medical analysis. By making high-quality diagnostics available at the point of care, Imagen seeks to improve early disease detection and patient outcomes. The vision is to ensure that all patients receive accurate and timely diagnoses, reducing unnecessary medical complications. Imagen continues to develop its technology to make AI-powered diagnostic imaging a key part of primary healthcare worldwide.

Imagen Technologies has received recognition for its advancements in AI-powered diagnostic imaging. Its FDA-cleared AI software has been acknowledged for improving diagnostic accuracy and reducing medical errors. The company has been featured in healthcare and technology publications for its impact on primary care. Imagen has also secured $75 million in Series C funding, reflecting strong investor confidence. Clinical studies have shown a 73% reduction in life-threatening clinical misses and a 96% patient satisfaction rate. The company continues to be recognised for making high-quality diagnostic imaging more accessible, improving early disease detection, and enhancing efficiency in primary healthcare.

Imagen Technologies provides a range of AI-powered diagnostic imaging products and services designed to improve medical accuracy, efficiency, and accessibility in primary care. The company integrates artificial intelligence with diagnostic imaging, allowing primary care physicians to conduct on-site imaging, receive real-time analysis, and consult with specialists without referring patients to external imaging centres. Its solutions aim to reduce diagnostic errors, improve early disease detection, and enhance patient care.

The company offers permanent on-site diagnostic imaging, which allows primary care practices to conduct medical imaging within their own facilities. This eliminates the need for external referrals, reduces waiting times, and enables physicians to provide immediate diagnostic results. Patients can receive their test results on the same day, leading to faster treatment decisions. The on-site imaging service is supported by Imagen’s advanced AI-powered software, which analyses medical images and provides automated diagnostic insights to assist doctors in making accurate assessments.

Imagen’s FDA-cleared AI software includes several specialised diagnostic tools. OsteoDetect is designed to identify distal radius fractures in wrist X-rays. This software assists doctors in detecting fractures that might be difficult to spot with the naked eye, reducing missed diagnoses and improving patient care. FractureDetect is another AI-powered tool that helps identify fractures in the musculoskeletal system. By providing detailed imaging analysis, it eliminates errors that often occur in manual X-ray reviews. ChestCAD is an AI system that analyses chest X-rays, identifying suspicious regions and categorising abnormalities. This tool is particularly useful for detecting lung conditions and other thoracic diseases at an early stage, allowing physicians to intervene before conditions worsen.

In addition to AI-powered imaging, Imagen Technologies offers a TeleSpecialist Network, providing virtual access to board-certified specialists. This service allows primary care doctors to consult with specialists in fields such as cardiology, orthopaedics, and radiology without requiring patients to visit another healthcare provider. The virtual consultation feature ensures that patients receive expert opinions quickly, improving the speed and accuracy of diagnoses.

The company also provides a Diagnostic Bundle, which includes in-office imaging equipment, AI-powered software, and complete end-to-end support for healthcare practices. This service ensures that clinics have access to high-quality diagnostic tools without needing to invest in expensive imaging equipment separately. Imagen manages the installation, maintenance, and technical support, allowing physicians to focus on patient care rather than operational concerns.

Imagen’s Interpretation + AI service combines the expertise of board-certified radiologists with advanced AI-powered diagnostics. Medical images are analysed by Imagen’s AI software, and final reports are reviewed and verified by expert radiologists to ensure accuracy and consistency. This combination of AI and human expertise reduces the likelihood of misdiagnoses and ensures reliable results for patients.

The company’s cloud-based diagnostic data infrastructure supports seamless integration into healthcare facilities. This infrastructure allows physicians to access medical images and diagnostic reports securely from any location, ensuring smooth workflows and efficient patient management. Imagen’s cloud system also ensures that patient data is protected while allowing for easy retrieval of past medical records.